Sen. Tim Scott leads bicameral letter urging FDA to reconsider gene therapy decision
March 27, 2026
March 27, 2026
WASHINGTON, March 27 -- Sen. Tim Scott, R-South Carolina, issued the following news release:
* * *
Sen. Tim Scott leads bicameral letter urging FDA to reconsider gene therapy decision
*
WASHINGTON -Today, U.S. Senator Tim Scott (R-SC) penned a letter to the U.S. Food and Drug Administration (FDA) urging the agency to reconsider and reverse a prior decision denying a Pediatric Rare Disease Priority Review Voucher (PRV) for a gene therapy treatin . . .
* * *
Sen. Tim Scott leads bicameral letter urging FDA to reconsider gene therapy decision
*
WASHINGTON -Today, U.S. Senator Tim Scott (R-SC) penned a letter to the U.S. Food and Drug Administration (FDA) urging the agency to reconsider and reverse a prior decision denying a Pediatric Rare Disease Priority Review Voucher (PRV) for a gene therapy treatin . . .